Form 4: Chemours Director Acquires Deferred Stock Units

Chemours Company director Courtney Mather acquired 2,226 deferred stock units, increasing total beneficial ownership to 6,216.3946 units.

Summary

• Courtney Mather, a director of The Chemours Company, acquired 2,226 deferred stock units (DSUs).
• The transaction occurred on December 31, 2025, and was made pursuant to a Rule 10b5-1(c) plan.
• Each deferred stock unit is the economic equivalent of one share of Chemours' common stock.
• The deferred stock units become payable upon the first month following Mather's termination of service as a director.
• Following this acquisition, Mather beneficially owns a total of 6,216.3946 deferred stock units, which includes dividend equivalent units.
• The derivative security price for the acquired units was $11.79.

Sentiment

Score: 6

Explanation: The acquisition of deferred stock units by a director is generally a positive signal, indicating alignment of interests and confidence in the company's future. However, it's a routine compensation event rather than a discretionary open-market purchase, so the positive sentiment is moderate.

Positives

• A director is increasing their beneficial ownership in the company through deferred stock units, which can signal confidence in the company's long-term prospects.
• The transaction was made under a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary acquisition.

Future Outlook

The deferred stock units are structured to become payable upon the first month following the reporting person's termination of service as a director, aligning the director's long-term interests with the company's performance.

Industry Context

This type of insider transaction, where directors acquire equity-linked compensation, is a common practice across industries to align management and director incentives with shareholder interests. Deferred stock units are a standard component of executive and director compensation packages, particularly in mature industrial chemical companies like Chemours, aiming to foster long-term commitment.

Comparison to Industry Standards

• The use of deferred stock units (DSUs) as a component of director compensation is a standard practice, comparable to compensation structures at peer companies in the specialty chemicals sector such as DuPont, PPG Industries, or Eastman Chemical Company.
• The acquisition of DSUs under a Rule 10b5-1 plan is a common mechanism for insiders to manage their equity holdings in a compliant and pre-planned manner, similar to practices observed at other publicly traded companies.

Stakeholder Impact

• Shareholders: The acquisition of DSUs by a director aligns their interests with shareholders, potentially fostering long-term value creation.

Next Steps

• The deferred stock units will become payable upon the first month following Courtney Mather's termination of service as a director.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units by a director as part of their compensation, executed under a Rule 10b5-1 plan. It indicates alignment of interests but does not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.

Keywords

Chemours, CC, Deferred Stock Units, DSU, Insider Transaction, Form 4, Director Compensation, Equity Acquisition, Rule 10b5-1